Popa O, Balas M, Golu I, Amzar D, Varcus F, Cornianu M
J Clin Med. 2024; 13(15).
PMID: 39124658
PMC: 11312762.
DOI: 10.3390/jcm13154391.
Park J, An S, Bae J, Kim J, Kim K
Front Endocrinol (Lausanne). 2024; 15:1382124.
PMID: 38711981
PMC: 11070936.
DOI: 10.3389/fendo.2024.1382124.
Makimattila S, Harjutsalo V, Feodoroff M, Groop P
J Endocr Soc. 2024; 8(5):bvae054.
PMID: 38558856
PMC: 10979775.
DOI: 10.1210/jendso/bvae054.
Palella M, Giustolisi F, Modica Fiascaro A, Fichera M, Palmieri A, Cannarella R
Cancers (Basel). 2023; 15(10).
PMID: 37345061
PMC: 10216403.
DOI: 10.3390/cancers15102724.
Choi S, Lee J, Kim Y, Chung Y, Choi S, Kim N
Korean J Clin Oncol. 2023; 16(1):25-32.
PMID: 36945302
PMC: 9942713.
DOI: 10.14216/kjco.20005.
De Novo Extra-Thyroidal Manifestations of Graves' Disease presenting 16 Years after Total Thyroidectomy for Thyroid Cancer.
Kwee A, Yong K, Seah L, Chng C
J ASEAN Fed Endocr Soc. 2021; 36(2):216-219.
PMID: 34966209
PMC: 8666488.
DOI: 10.15605/jafes.036.02.08.
Clinical Characteristics and Prognosis of Coexisting Thyroid Cancer in Patients with Graves' Disease: A Retrospective Multicenter Study.
Yoon J, Jin M, Kim M, Hong A, Kim H, Kim B
Endocrinol Metab (Seoul). 2021; 36(6):1268-1276.
PMID: 34823306
PMC: 8743582.
DOI: 10.3803/EnM.2021.1227.
Association between Urinary Iodine Concentration and Thyroid Nodules in Adults: A Cross-Sectional Study in China.
Sun H, Wang H, Lian X, Liu C, Shi B, Shi L
Biomed Res Int. 2020; 2020:4138657.
PMID: 33381554
PMC: 7762642.
DOI: 10.1155/2020/4138657.
Frequency of thyroid nodules and thyroid cancer in thyroidectomized patients with Graves' disease.
Keskin C, Sahin M, Hasanov R, Aydogan B, Demir O, Emral R
Arch Med Sci. 2020; 16(2):302-307.
PMID: 32190140
PMC: 7069426.
DOI: 10.5114/aoms.2018.81136.
Pitfalls in Thyroid Cytopathology.
Rossi E, Adeniran A, Faquin W
Surg Pathol Clin. 2019; 12(4):865-881.
PMID: 31672295
PMC: 7404573.
DOI: 10.1016/j.path.2019.08.001.
Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves' disease patients: a retrospective matched cohort study.
You E, Mascarella M, Al Jassim A, Forest V, Hier M, Tamilia M
J Otolaryngol Head Neck Surg. 2019; 48(1):40.
PMID: 31462328
PMC: 6714443.
DOI: 10.1186/s40463-019-0364-5.
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study.
Premoli P, Tanda M, Piantanida E, Veronesi G, Gallo D, Masiello E
J Endocrinol Invest. 2019; 43(1):109-116.
PMID: 31327128
DOI: 10.1007/s40618-019-01088-5.
Positive Antithyroid Antibodies and Nonsuppressed TSH Are Associated with Thyroid Cancer: A Retrospective Cross-Sectional Study.
Kratky J, Jezkova J, Kosak M, Vitkova H, Bartakova J, Mraz M
Int J Endocrinol. 2018; 2018:9793850.
PMID: 30258461
PMC: 6146563.
DOI: 10.1155/2018/9793850.
Preoperative Preparation of Hyperthyroidism for Thyroidectomy - Role of Supersaturated Iodine and Lithium Carbonate.
Nair G, J C Babu M, Menon R, Jacob P
Indian J Endocrinol Metab. 2018; 22(3):392-396.
PMID: 30090733
PMC: 6063166.
DOI: 10.4103/ijem.IJEM_3_18.
The Outcome of Papillary Thyroid Cancer Associated with Graves' Disease: A Case Control Study.
Menon R, Nair C, Babu M, Jacob P, Krishna G
J Thyroid Res. 2018; 2018:8253094.
PMID: 29854383
PMC: 5964588.
DOI: 10.1155/2018/8253094.
Does hyperthyroidism worsen prognosis of thyroid carcinoma? A retrospective analysis on 2820 consecutive thyroidectomies.
Medas F, Erdas E, Canu G, Longheu A, Pisano G, Tuveri M
J Otolaryngol Head Neck Surg. 2018; 47(1):6.
PMID: 29357932
PMC: 5778700.
DOI: 10.1186/s40463-018-0254-2.
Time course of Graves' orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer.
Louvet C, De Bellis A, Pereira B, Bournaud C, Kelly A, Maqdasy S
Medicine (Baltimore). 2016; 95(48):e5474.
PMID: 27902601
PMC: 5134772.
DOI: 10.1097/MD.0000000000005474.
Prognostic biomarkers in thyroid cancer.
Soares P, Celestino R, Melo M, Fonseca E, Sobrinho-Simoes M
Virchows Arch. 2014; 464(3):333-46.
PMID: 24487783
DOI: 10.1007/s00428-013-1521-2.
Anaplastic thyroid carcinoma following radioactive iodine therapy for graves' disease.
Kim S, Kim H, Jung K, Choi D, Kim S
Endocrinol Metab (Seoul). 2014; 28(1):61-4.
PMID: 24396653
PMC: 3811800.
DOI: 10.3803/EnM.2013.28.1.61.
Predictive factors of thyroid cancer in patients with Graves' disease.
Ren M, Wu M, Shang C, Wang X, Zhang J, Cheng H
World J Surg. 2013; 38(1):80-7.
PMID: 24166025
DOI: 10.1007/s00268-013-2287-z.
